Paper29434873
Mechanisms by which CXCR4/CXCL12 cause metastatic behavior in pancreatic cancer.
Zhang J and 4 others. Oncol Lett, 2018. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Mechanisms by which CXCR4/CXCL12 cause metastatic behavior in pancreatic cancer. Papers, record 29434873. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29434873
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17903729 | Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. | J Am Coll Surg | 2007 | https://conductscience.org/library/papers/17903729 | PubMed |
| 2 | 24998559 | Study on the relationship between CXCR4 expression and perineural invasion in pancreatic cancer. | Asian Pac J Cancer Prev | 2014 | https://conductscience.org/library/papers/24998559 | PubMed |
| 3 | 26356032 | CXCR4 in breast cancer: oncogenic role and therapeutic targeting. | Drug Des Devel Ther | 2015 | https://conductscience.org/library/papers/26356032 | PubMed |
| 4 | 25287686 | The intricate role of CXCR4 in cancer. | Adv Cancer Res | 2014 | https://conductscience.org/library/papers/25287686 | PubMed |
| 5 | 24840182 | Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4. | Cancer Biol Ther | 2014 | https://conductscience.org/library/papers/24840182 | PubMed |
| 6 | 15164986 | CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells. | J Neurooncol | 2004 | https://conductscience.org/library/papers/15164986 | PubMed |
| 7 | 11929756 | Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. | Blood | 2002 | https://conductscience.org/library/papers/11929756 | PubMed |
| 8 | 12388552 | CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12388552 | PubMed |
| 9 | 24033967 | Role of CXCL12/CXCR4 signaling axis in pancreatic cancer. | Chin Med J (Engl) | 2013 | https://conductscience.org/library/papers/24033967 | PubMed |
| 10 | 26361402 | Early detection of pancreatic cancer. | Chin J Cancer Res | 2015 | https://conductscience.org/library/papers/26361402 | PubMed |
| 11 | 15051286 | Pancreatic cancer. | Lancet | 2004 | https://conductscience.org/library/papers/15051286 | PubMed |
| 12 | 11726975 | Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. | Nat Med | 2001 | https://conductscience.org/library/papers/11726975 | PubMed |
| 13 | 23181100 | CXCL12/CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: A clinical study. | Exp Ther Med | 2012 | https://conductscience.org/library/papers/23181100 | PubMed |
| 14 | 21620466 | Pancreatic cancer. | Lancet | 2011 | https://conductscience.org/library/papers/21620466 | PubMed |
| 15 | 17089032 | Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease. | Oncol Rep | 2006 | https://conductscience.org/library/papers/17089032 | PubMed |
| 16 | 26338423 | EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway. | Sci Rep | 2015 | https://conductscience.org/library/papers/26338423 | PubMed |
| 17 | 22143577 | Surveillance of pancreatic cancer patients after surgical resection. | Ann Surg Oncol | 2012 | https://conductscience.org/library/papers/22143577 | PubMed |
| 18 | 21412497 | Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. | World J Gastroenterol | 2011 | https://conductscience.org/library/papers/21412497 | PubMed |
| 19 | 22237781 | Cancer statistics, 2012. | CA Cancer J Clin | 2012 | https://conductscience.org/library/papers/22237781 | PubMed |
| 20 | 17923814 | Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2. | Eur J Cancer Prev | 2007 | https://conductscience.org/library/papers/17923814 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42811017 | Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives. | Nat Commun | 2026 | https://conductscience.org/library/papers/42811017 | PubMed |
| 42040173 | Pancreatic Lymphatics in Health and Disease: Evolution, Embryology, and Neural Control. | Lymphatics | 2026 | https://conductscience.org/library/papers/42040173 | PubMed |
| 41991735 | A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinoma. | Sci Rep | 2026 | https://conductscience.org/library/papers/41991735 | PubMed |
| 41703564 | Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway. | J Transl Med | 2026 | https://conductscience.org/library/papers/41703564 | PubMed |
| 41694374 | CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2-CCL2, CCR5-CCL5, CCR4-CCL17/22, CCR6-CCL20, CCR7-CCL19/21. | Front Immunol | 2026 | https://conductscience.org/library/papers/41694374 | PubMed |
| 41138017 | Lymphatic metastasis in pancreatic cancer: from bedside to bench and back. | Cancer Metastasis Rev | 2025 | https://conductscience.org/library/papers/41138017 | PubMed |
| 40123816 | Expression of CXCR4 in the Primary Lesion of Recurrent Metastatic Breast Cancer and Its Association With Prognosis. | Int J Gen Med | 2025 | https://conductscience.org/library/papers/40123816 | PubMed |
| 38652207 | Anti-cancer potential of zerumbone in cancer and glioma: current trends and future perspectives. | Med Oncol | 2024 | https://conductscience.org/library/papers/38652207 | PubMed |
| 38540782 | A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present. | Biomolecules | 2024 | https://conductscience.org/library/papers/38540782 | PubMed |
| 38253803 | The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients. | Nat Cancer | 2024 | https://conductscience.org/library/papers/38253803 | PubMed |
| 37697316 | The importance of CXCR4 expression in tumor stroma as a potential biomarker in pancreatic cancer. | World J Surg Oncol | 2023 | https://conductscience.org/library/papers/37697316 | PubMed |
| 36512927 | Effect of tocopherol conjugation on polycation-mediated siRNA delivery to orthotopic pancreatic tumors. | Biomater Adv | 2023 | https://conductscience.org/library/papers/36512927 | PubMed |
| 36359736 | CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients. | Cells | 2022 | https://conductscience.org/library/papers/36359736 | PubMed |
| 36302761 | Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma. | Nat Commun | 2022 | https://conductscience.org/library/papers/36302761 | PubMed |
| 36112544 | Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets. | Clin Cancer Res | 2022 | https://conductscience.org/library/papers/36112544 | PubMed |
| 36077755 | Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36077755 | PubMed |
| 35800881 | Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting. | Stem Cells Int | 2022 | https://conductscience.org/library/papers/35800881 | PubMed |
| 35269786 | CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35269786 | PubMed |
| 35188730 | Nanoemulsion-Assisted siRNA Delivery to Modulate the Nervous Tumor Microenvironment in the Treatment of Pancreatic Cancer. | ACS Appl Mater Interfaces | 2022 | https://conductscience.org/library/papers/35188730 | PubMed |
| 35119076 | Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer. | Oncol Rep | 2022 | https://conductscience.org/library/papers/35119076 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| CXCL12 | 6387 | PubTator's text mining | https://conductscience.org/library/genes/6387 | NCBI Gene |
| CXCR4 | 7852 | PubTator's text mining | https://conductscience.org/library/genes/7852 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| VEGFC | 7424 | PubTator's text mining | https://conductscience.org/library/genes/7424 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29434873
GET https://conductscience.org/api/papers/v1/29434873/references?page=2